Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy
T cell function can be compromised during chronic infections or through continuous exposure to tumor antigens by the action of immune checkpoint receptors, such as programmed cell death protein 1 (PD-1). Systemic administration of blocking antibodies against the PD-1 pathway can restore T cell funct...
Main Authors: | Zhang, C, Peng, Y, Hublitz, P, Zhang, H, Dong, T |
---|---|
Format: | Journal article |
Published: |
Springer Nature
2018
|
Similar Items
-
Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy
by: Deepa Kolaseri Krishnadas, et al.
Published: (2017-07-01) -
CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01) -
Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
by: Brian J. Ahn, et al.
Published: (2013-11-01) -
New development of Immune checkpoints blockade in cancer immunotherapy
by: Wu Feixuan
Published: (2019-01-01) -
Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
by: Oelke, M, et al.
Published: (2000)